The current global pharmaceutical dynamics have ensured a shift towards collaborative relationships. By establishing key capabilities in CRAM, Centaur has strategically positioned itself to offer critical value.

A fully scalable 25,000 square metres formulations facility conforming to USFDA / European standards has been set up in Pune for contract manufacturing. The facility is dedicated to oral solids and sterile products.

The capacities of the facility on a single shift basis are:

• 3 billion tablets
• 600 million capsules
• 20 million, vials and ampoules (Proposed)
• 12 million units ophthalmic drops (Under expansion)